van Leeuwen FE - Search Results

1

The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

Broeks A, Braaf LM, Huseinovic A, Schmidt MK, Russell NS, van Leeuwen FE, Hogervorst FB, Van 't Veer LJ. Broeks A, et al. Among authors: van t veer lj, van leeuwen fe. Breast Cancer Res Treat. 2008 Jan;107(2):243-8. doi: 10.1007/s10549-007-9543-6. Epub 2007 Mar 28. Breast Cancer Res Treat. 2008. PMID: 17393301 Free PMC article.

2

Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation.

Klaren HM, van't Veer LJ, van Leeuwen FE, Rookus MA. Klaren HM, et al. Among authors: van t veer lj, van leeuwen fe. J Natl Cancer Inst. 2003 Jul 2;95(13):941-7. doi: 10.1093/jnci/95.13.941. J Natl Cancer Inst. 2003. PMID: 12837830 Review. No abstract available.

3

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS. van Leeuwen FE, et al. Among authors: van t veer mb. J Natl Cancer Inst. 2003 Jul 2;95(13):971-80. doi: 10.1093/jnci/95.13.971. J Natl Cancer Inst. 2003. PMID: 12837833

4

Re: Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?

Aleman BM, Russell NS, Bartelink H, van Leeuwen FE. Aleman BM, et al. Among authors: van leeuwen fe. J Natl Cancer Inst. 2004 Feb 4;96(3):235-6; author reply 236-7. doi: 10.1093/jnci/djh035. J Natl Cancer Inst. 2004. PMID: 14759992 Free article. No abstract available.

5

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers.

Broeks A, de Witte L, Nooijen A, Huseinovic A, Klijn JG, van Leeuwen FE, Russell NS, van't Veer LJ. Broeks A, et al. Among authors: van t veer lj, van leeuwen fe. Breast Cancer Res Treat. 2004 Jan;83(1):91-3. doi: 10.1023/B:BREA.0000010697.49896.03. Breast Cancer Res Treat. 2004. PMID: 14997059

6

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Van't Veer L, Van Leeuwen FE, Goldgar DE. Andrieu N, et al. Among authors: van t veer l, van leeuwen fe. J Clin Oncol. 2006 Jul 20;24(21):3361-6. doi: 10.1200/JCO.2005.03.3126. Epub 2006 Jun 26. J Clin Oncol. 2006. PMID: 16801631

7

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT, Peterse JL, van Leeuwen FE, Van't Veer LJ. Schmidt MK, et al. Among authors: van t veer lj, van leeuwen fe. J Clin Oncol. 2007 Jan 1;25(1):64-9. doi: 10.1200/JCO.2006.06.3024. Epub 2006 Nov 28. J Clin Oncol. 2007. PMID: 17132695

8

Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.

Vrieling A, Rookus MA, Kampman E, Bonfrer JM, Korse CM, van Doorn J, Lampe JW, Cats A, Witteman BJ, van Leeuwen FE, van't Veer LJ, Voskuil DW. Vrieling A, et al. Among authors: van t veer lj, van doorn j, van leeuwen fe. J Nutr. 2007 Feb;137(2):379-83. doi: 10.1093/jn/137.2.379. J Nutr. 2007. PMID: 17237315 Free article. Clinical Trial.

9

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

Broeks A, Braaf LM, Huseinovic A, Nooijen A, Urbanus J, Hogervorst FB, Schmidt MK, Klijn JG, Russell NS, Van Leeuwen FE, Van 't Veer LJ. Broeks A, et al. Among authors: van t veer lj, van leeuwen fe. Breast Cancer Res. 2007;9(2):R26. doi: 10.1186/bcr1668. Breast Cancer Res. 2007. PMID: 17428320 Free PMC article.

10

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.

Brohet RM, Goldgar DE, Easton DF, Antoniou AC, Andrieu N, Chang-Claude J, Peock S, Eeles RA, Cook M, Chu C, Noguès C, Lasset C, Berthet P, Meijers-Heijboer H, Gerdes AM, Olsson H, Caldes T, van Leeuwen FE, Rookus MA. Brohet RM, et al. Among authors: van leeuwen fe. J Clin Oncol. 2007 Sep 1;25(25):3831-6. doi: 10.1200/JCO.2007.11.1179. Epub 2007 Jul 16. J Clin Oncol. 2007. PMID: 17635951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

493 results

Search Page